The purpose of the Flow Cytometry Shared Resource (FCSR) is to provide comprehensive cytoflourometric analysis and sorting to the YCC investigators and the broader YSM community. The facility not only provides, maintains, and operates the instruments, but also trains users, develops techniques, provides protocols, and manages access and the financial aspects of the Shared Resource. Until the winter of 2004, YSM had two entities that provided FACS services: the YCC FCSR and the Immunobiology (1MB) FACS facility. The former was supported by the YCC grant and user fees while the latter was subsidized in part by Howard Hughes Medical Institute (HHMI), which owned some of the instruments and paid their service contracts. The YCC Shared Resource had a slow-speed sorter and also had access to a FACSCalibur. In winter of 2002, YSM opened a new research building which was to house all of 1MB as well as many YSM faculty members doing immunologically-related research. Using space donated in part by the Dept. of Medicine and in part by Immunobiology (1MB), the school agreed to customdesign space to house an expanded FACS Core that would now be open to 1MB as well as the Dept. of Medicine. In addition, individual units within Medicine donated three FACS Calibur machines to the newly constituted core. At the same time, the FACS Core Director (now YCC FCSR Director) had obtained a shared instrument grant for a new sorter, and a FACS Aria was installed in the fall of 2002. Finally, the YSM purchased for this facility a used MoFlo sorter. Since the YCC FCSR continued to have limited equipment and space, it was decided to improve the quality and scope of services available to YCC members by merging the two facilities. In concert with this, the YCC agreed to partially subsidize the purchase of an LSRII analyzer and to direct its current user subsidy budget towards an employee of the now-merged facility. The facility thus has three high-speed sorters, 4 FACSCaliburs, a FACScan and LSRII. These instruments are housed in TAG S613 and S617, with a Mac and a PC based workstation for data analysis adjacent. It is used by 117 different Pis and has 486 trained users, who together used 3,952 hrs of sorting and 11,915 hrs of analysis in 2005, of which 61 YCC members represented 80% (77% peer-reviewed) and 87% (83% peerreviewed) respectively of total use. Members of 7 of 8 of YCC Research Programs utilized the FCSR.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016359-32
Application #
8132527
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
32
Fiscal Year
2010
Total Cost
$158,474
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Wadia, Roxanne J; Stolar, Marilyn; Grens, Clarice et al. (2018) The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients. Oncotarget 9:7322-7331
De Feyter, Henk M; Behar, Kevin L; Corbin, Zachary A et al. (2018) Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Sci Adv 4:eaat7314
Ventura, Alessandra; Vassall, Aaron; Robinson, Eve et al. (2018) Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity. Cancer Res 78:4045-4058
Xiao, Qian; Wu, Jibo; Wang, Wei-Jia et al. (2018) DKK2 imparts tumor immunity evasion through ?-catenin-independent suppression of cytotoxic immune-cell activation. Nat Med 24:262-270
Jagannath, Sundar; Laubach, Jacob; Wong, Ellice et al. (2018) Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study. Br J Haematol 182:495-503
Liu, Xiaoni; Zhang, Shang-Min; McGeary, Meaghan K et al. (2018) KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations. Mol Cancer Ther :
Chae, Wook-Jin; Bothwell, Alfred L M (2018) Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside. Front Immunol 9:303
Kim, Hanseul; Keum, NaNa; Giovannucci, Edward L et al. (2018) Garlic intake and gastric cancer risk: Results from two large prospective US cohort studies. Int J Cancer 143:1047-1053
Sarma, Elizabeth A; Kawachi, Ichiro; Poole, Elizabeth M et al. (2018) Social integration and survival after diagnosis of colorectal cancer. Cancer 124:833-840
Hartman, Douglas J; Ahmad, Fahad; Ferris, Robert L et al. (2018) Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Oral Oncol 86:278-287

Showing the most recent 10 out of 675 publications